PreveCeutical Medical Inc. (CSE:PREV)
Canada · Delayed Price · Currency is CAD 0.0250
0.00 (0.00%)
Aug 28, 2026, 9:30 AM EST
PreveCeutical Medical Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -0.65 | -1.58 | -1.17 | -1.27 | -1.48 | -1.73 |
Depreciation & Amortization | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Loss (Gain) From Sale of Assets | -2.01 | -2.01 | - | - | -0 | 0 |
Loss (Gain) on Equity Investments | 0.18 | 0.02 | - | - | - | - |
Stock-Based Compensation | 0.1 | 0.67 | 0.08 | 0.13 | 0.33 | 0.09 |
Provision & Write-off of Bad Debts | - | - | - | - | 0.04 | - |
Other Operating Activities | 0.17 | 0.21 | 0.32 | 0.31 | 0.38 | 0.61 |
Change in Accounts Receivable | -0 | 0.01 | -0.02 | 0.01 | -0 | 0.04 |
Change in Accounts Payable | 0.49 | 0.93 | 0.34 | 0.53 | 0.52 | 0.55 |
Change in Other Net Operating Assets | 0.11 | 0.03 | 0.03 | -0.02 | -0.03 | 0.01 |
Operating Cash Flow | -1.6 | -1.72 | -0.43 | -0.3 | -0.22 | -0.43 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0 | -0 | -0 | - | - | - |
Sale of Property, Plant & Equipment | - | - | - | - | 0 | 0 |
Sale (Purchase) of Intangibles | 0.06 | - | - | - | - | -0.06 |
Investing Cash Flow | 0.06 | -0 | -0 | - | 0 | -0.05 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 0.07 | 0.32 | 0.29 | 0.22 | 0.19 |
Long-Term Debt Issued | - | - | - | - | - | 0.09 |
Total Debt Issued | 0.07 | 0.07 | 0.32 | 0.29 | 0.22 | 0.28 |
Short-Term Debt Repaid | - | -0.17 | -0.07 | - | - | -0.14 |
Total Debt Repaid | -0.11 | -0.17 | -0.07 | - | - | -0.14 |
Net Debt Issued (Repaid) | -0.03 | -0.1 | 0.25 | 0.29 | 0.22 | 0.14 |
Issuance of Common Stock | 1.6 | 1.78 | 0.24 | - | - | - |
Other Financing Activities | - | - | - | - | -0.01 | - |
Financing Cash Flow | 1.57 | 1.68 | 0.49 | 0.29 | 0.21 | 0.14 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.01 | -0 | -0 | -0 | -0 | 0.2 |
Net Cash Flow | 0.03 | -0.05 | 0.06 | -0 | -0.01 | -0.14 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.6 | -1.72 | -0.43 | -0.3 | -0.22 | -0.43 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
Levered Free Cash Flow | -2.59 | -2.51 | -0.25 | -0.1 | -0.25 | -0.29 |
Unlevered Free Cash Flow | -2.39 | -2.31 | -0.04 | 0.1 | -0.1 | 0 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0 | 0 | 0.01 | 0 | 0 | 0 |
Change in Working Capital | 0.6 | 0.96 | 0.34 | 0.53 | 0.49 | 0.59 |